Find a Doctor

HC
Areas of Expertise

Hyun C. Chung

Yonsei University College Of Medicine

Bio

Hyun Chung is in Seoul, Republic of Korea. They have been an author on 532 peer reviewed articles and participated in 1 clinical trial in the past 15 years.

Areas of Expertise

Contact

Seoul, KR

Latest Advances

Latest Advance
Study
  • Condition: HER2-Positive Gastric Cancer
  • Journal: The New England journal of medicine
  • Treatment Used: Trastuzumab Deruxtecan
  • Number of Patients: 187
  • Published —
The study researched the safety and effectiveness of Trastuzumab Deruxtecan in treating HER2-positive gastric cancer.
Latest Advance
Study
  • Condition: Untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer
  • Journal: Annals of oncology : official journal of the European Society for Medical Oncology
  • Treatment Used: Nivolumab in combination with S-1/capecitabine plus oxaliplatin
  • Number of Patients: 40
  • Published —
The study researched using Nivolumab in combination with S-1/capecitabine plus oxaliplatin for untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer.
Latest Advance
Study
  • Condition: Advanced Gastric or Gastroesophageal Junction Cancer
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Avelumab
  • Number of Patients: 150
  • Published —
This study tested the safety and efficacy of using avelumab to treat patients with advanced gastric or gastroesophageal junction cancer.
Latest Advance
Study
  • Condition: Locally advanced or metastatic gastric (stomach) or gastroesophageal junction cancer
  • Journal: European journal of cancer (Oxford, England : 1990)
  • Treatment Used: mFOLFOX6 with or without the Akt inhibitor ipatasertib
  • Number of Patients: 153
  • Published —
The study researched the outcomes of mFOLFOX6 with or without the Akt inhibitor ipatasertib in treating locally advanced or metastatic gastric or gastroesophageal junction cancer.
Latest Advance
Study
  • Condition: Untreated, Unresectable, Advanced, or Recurrent Gastric/Gastroesophageal Junction Cancer
  • Journal: Annals of oncology : official journal of the European Society for Medical Oncology
  • Treatment Used: Nivolumab with S-1/Capecitabine plus Oxaliplatin
  • Number of Patients: 40
  • Published —
This study tested the safety and efficacy of using nivolumab with S-1/capecitabine plus oxaliplatin to treat patients with untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer.
Latest Advance
Study
  • Condition: Gastric cancer
  • Journal: BMC cancer
  • Treatment Used: Conversion surgery following chemotherapy
  • Number of Patients: 101
  • Published —
This study investigated the efficacy of conversion surgery after chemotherapy for patients with stage IV gastric cancer.
Latest Advance
Study
  • Condition: Advanced Triple-Negative Breast Cancer (TNBC)
  • Journal: Clinical breast cancer
  • Treatment Used: Ixabepilone in Combination with Capecitabine
  • Number of Patients: 443
  • Published —
This study evaluated the safety and effectiveness of ixabepilone in combination with capecitabine in patients with metastatic or locally advanced triple-negative breast cancer (TNBC).
Latest Advance
Study
  • Condition: Gastric cancer
  • Journal: Cancer research and treatment : official journal of Korean Cancer Association
  • Treatment Used: S-1 plus docetaxel versus S-1 plus cisplatin
  • Number of Patients: 153
  • Published —
This study compared the effects of S-1 plus docetaxel versus S-1 plus cisplatin as an adjuvant chemotherapy for stage III gastric cancer patients.
Latest Advance
Study
  • Condition: Advanced Head And Neck Squamous Cell Carcinoma
  • Journal: Cancer science
  • Treatment Used: Pembrolizumab
  • Number of Patients: 26
  • Published —
The purpose of the study was to investigate the effectiveness and safety of pembrolizumab with recurrent/metastatic head and neck squamous cell carcinoma.

Clinical Trials

This doctor has not participated in any recent clinical trials.

All Publications
View All

Publication
Study
  • Journal: The New England journal of medicine
  • Published —
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer.
Publication
Study
  • Journal: Annals of oncology : official journal of the European Society for Medical Oncology
  • Published —
KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer.

Contact

Seoul, KR

Insurance

Contact them to find out if they accept your insurance plan.